Injective: Bearish trend and oversold signals drive 7.72% daily gain

Traders Union
All News
Crypto News
Injective surges 7.72% to $3.25 today

Highlights

Injective Protocol operates as a decentralized network governed by INJ token holders, with a market capitalization of $335.41 million as of June 2024.
INJ posted a 24-hour trading volume of $62.69 million, reflecting active liquidity despite broader market pressure.
The INJ price at $3.25 trades below all major moving averages, with technical indicators showing persistent bearish momentum and a high likelihood of further downside.

Decentralized governance and moderate flows shape INJ's trading backdrop

Injective Protocol, launched on October 17, 2020, operates as a decentralized, publicly managed network governed by INJ token holders. The current market capitalization is reported at $335.41 million, with a trading volume of $62.69 million over the last 24 hours.

Deep oversold readings diverge from entrenched bearish momentum

The nearest dynamic resistance for INJ is the Ichimoku Kijun at $4.36, with the price sitting well beneath all major moving averages and limited immediate support. Momentum indicators on the daily chart remain bearish: MACD and ADX both signal persistent sell conditions, and most oscillators, including RSI at 23.72, Commodity Channel Index at –152.95, and Stochastic RSI in oversold territory, highlight deeply oversold circumstances. Bull/Bear Power at –0.30 confirms ongoing seller dominance, while the Awesome Oscillator aligns with the downtrend. Despite a sharp intraday recovery near today’s session highs and elevated volatility, there is a notable divergence between oversold oscillators and ongoing strong bearish momentum.

Downside favored amid muted rebound odds and compressed price range

Looking ahead, the expected price range for INJ over the next five trading days is $2.95 to $3.60, representing a typical volatility band relative to current levels. The probability of a price increase is very low (less than 20%), indicating that further decline is much more likely in the short term. The baseline scenario sees INJ trading sideways under pressure between $2.95 and $3.60. A bullish rebound could target resistance at $3.60 and possibly the Ichimoku Kijun at $4.36, while renewed selling below $2.95 would open further downside. Overall, momentum and trend signals favor the downside, yet oversold conditions suggest the potential for brief counter-trend rallies.

Anton Kharitonov, expert at Traders Union, sees clear bearish dominance for Injective as the price stays below all major moving averages. He notes strong selling momentum and oversold readings, with little chance for a sustained rebound in the short term. Sideways or lower price action between $2.95 and $3.60 remains the base case. "With persistent sell signals and ongoing downside momentum, I remain cautious and see little incentive to consider longs until key resistance levels like $3.60 are reclaimed."

Previously it was reported that Injective is trading significantly below its key moving averages, with firm bearish momentum confirmed by negative MACD and sustained downside pressure. Oscillators including RSI, Stochastic RSI, and CCI signal oversold conditions, but the absence of nearby support and continued dominance by sellers suggest a high probability of further consolidation or decline unless the price reclaims resistance above the Ichimoku Kijun.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.